Tesamorelin – Research Peptide

Tesamorelin – Research Peptide
Class: Growth Hormone-Releasing Hormone (GHRH) analog  
Form: Lyophilized powder
Purity: ≥ 99% (HPLC verified)
Storage (dry): Room temperature, away from light
Storage (reconstituted): Refrigerate 2–8°C
Solvent compatibility: Bacteriostatic Water (preferred)  
Tesamorelin is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group. This modification enhances its stability and potency. In laboratory research, it is primarily studied for its ability to stimulate the synthesis and release of endogenous growth hormone by binding to the GHRH receptors in the pituitary gland.  
Key Research Focus Areas
Lipid Metabolism & Adipose Research: Investigation of the peptide's role in the reduction of visceral adipose tissue (VAT) in metabolic stress models.  
Pituitary Gland Signaling: Analysis of the GH-releasing mechanism and its subsequent effect on IGF-1 (Insulin-like Growth Factor 1) levels.
Cognitive Function Studies: Research into the potential neuroprotective effects and the influence of the GH/IGF-1 axis on hippocampal proteostasis.
Glucose Homeostasis: Evaluation of the impact of GHRH analogs on insulin sensitivity and carbohydrate metabolism in controlled settings.  
Cardiovascular Health Markers: Study of how growth hormone modulation affects carotid intima-media thickness and inflammatory markers.
Format Options
5 mg or 10 mg lyophilized powder
Optional BAC solvent available separately
Important Notice
All products are sold for laboratory research use only. Not for human consumption, injection, or diagnostic use.